In this episode of the Iowa Tech Podcast, host Kaylee engages in an insightful conversation with Buddy Lyons and Dr. John Cromwell, the co-founders of ENTAC Medical. The discussion delves into the innovative journey of ENTAC Medical, a company that has pioneered the use of acoustic biomarkers and artificial intelligence to predict adverse medical events. Buddy and John share the fascinating origin story of their company, which began with the development of a predictive medical device aimed at addressing postoperative ileus. With a strong commitment to transforming healthcare from a reactive to a predictive model, the duo highlights the challenges and triumphs they've faced, including the financial hurdles and technological breakthroughs that have shaped their path.

As the conversation unfolds, listeners gain valuable insights into the potential of ENTAC Medical's groundbreaking technology, which extends beyond gastrointestinal applications to broader medical conditions such as asthma and congestive heart failure. The episode showcases the strategic partnerships and academic collaborations that have fueled the company's growth, emphasizing the pivotal role of Iowa's burgeoning med-tech ecosystem. Buddy and John candidly discuss the lessons learned and the importance of persistence and adaptability in the entrepreneurial journey. With plans to expand their innovative platform and a vision for the future of healthcare, ENTAC Medical is a testament to the power of innovation and collaboration in driving transformative change in the medical field.

Find this show on your favorite app: https://iowapodcast.com/lyons-and-cromwell-acoustic-biomarkers-medtech